Jackson Square Partners’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-27,335
Closed -$2.67M 2
2025
Q3
$2.67M Sell
27,335
-7,714
-22% -$621K 1.08% 36
2025
Q2
$2.44M Sell
35,049
-175,295
-83% -$10M 0.9% 51
2025
Q1
$10.4M Buy
210,344
+23,754
+13% +$1.5M 1.41% 34
2024
Q4
$13M Sell
186,590
-56,757
-23% -$4.71M 1.36% 34
2024
Q3
$25.5M Sell
243,347
-119,596
-33% -$14M 2.2% 19
2024
Q2
$51.6M Sell
362,943
-129,821
-26% -$15M 3.15% 8
2024
Q1
$55M Buy
492,764
+162,040
+49% +$19.3M 2.29% 22
2023
Q4
$42.9M Buy
+330,724
New +$45.6M 1.39% 30

Other funds holding ACLS

Jackson Square Partners's ACLS Position: Q4 2025 in Review

Jackson Square Partners sold out of Axcelis (ACLS) in Q4 2025, closing a stake of 27,335 shares — an estimated $2.67M sold.

Jackson Square Partners first reported a position in ACLS in Q4 2023 and held it in 8 quarters. The position peaked at $55M in Q1 2024. 370 funds tracked by Wall St. Rank hold ACLS as of Q4 2025.

  • Jackson Square Partners reported no remaining Axcelis position as of Q4 2025 after selling out during the quarter.
  • Jackson Square Partners sold 27,335 Axcelis shares in Q4 2025, an estimated $2.67M.
  • Jackson Square Partners first reported a position in Axcelis in Q4 2023 and held it in 8 quarters.
  • Jackson Square Partners's Axcelis position peaked at $55M in Q1 2024.
  • 370 funds tracked by Wall St. Rank held Axcelis as of Q4 2025.

Based on Jackson Square Partners's 13F filing for Q4 2025.